By Femtech Insider Breast Health, Cancer, News, Pharma, Research July 15, 2026 ShareTwitterFacebookPinterest-circled FDA Approves Celcuity’s REVTORPYK for HR+/HER2-, PIK3CA Wild-Type Advanced Breast Cancer
By Femtech Insider Hormonal Health, News, Pharma, Research July 15, 2026 ShareTwitterFacebookPinterest-circled Veradermics Reports Positive Phase 2 Results for Oral Non-Hormonal Hair Loss Drug in Women
By Femtech Insider Breast Health, Cancer, News, Pharma July 13, 2026 ShareTwitterFacebookPinterest-circled Roche’s Genentech Signs $490M Breast Cancer Drug Discovery Deal with Astex Pharmaceuticals
By Femtech Insider News, Pharma, Reproductive Health July 7, 2026 ShareTwitterFacebookPinterest-circled Organon Licenses Hormone-Free Copper IUD MIUDELLA for Global Commercialization
By Femtech Insider Breast Health, News, Pharma, Regulatory May 26, 2026 ShareTwitterFacebookPinterest-circled FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years
By Femtech Insider Breast Health, Cancer, News, Pharma May 19, 2026 ShareTwitterFacebookPinterest-circled FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
By Femtech Insider Acquisition, News, Pharma April 28, 2026 ShareTwitterFacebookPinterest-circled Sun Pharma to Acquire Women’s Health Pharma Giant Organon in $11.75 Billion Deal
By Femtech Insider Biotech, Investor, News, Pharma April 9, 2026 ShareTwitterFacebookPinterest-circled European Biopharma Investor Jeito Capital Closes $1.2B Fund
